Investor Relations
print page
News
February 4, 2019
Targeted Medical Pharma Forms Distribution Partnership with Cannabinoid Genetic Research Firm, ENDOCANNA Health
October 18, 2018
Targeted Medical Pharma Files SEC Form 15
January 13, 2016
Targeted Medical Pharma Finalizes Exclusive Agreement for Distribution in CHINA
September 8, 2015
Research Identifies a Potential New Path to Developing a Treatment for Chronic Pain
April 27, 2015
New Research Finds a Link Between Obesity and Nutritional Deficiencies
February 19, 2015
Targeted Medical Pharma Announces New Partnership for Exclusive Distribution in Japan
January 29, 2015
Targeted Medical Pharma Announces Changes in Management and Board of Directors
November 18, 2014
Targeted Medical Pharma, Inc. Announces Q3 Financial Results and Clinical Program Updates
October 13, 2014
Targeted Medical Pharma Releases Promising Trial Results for the Treatment of Posttraumatic Stress Disorder
October 6, 2014
Targeted Medical Pharma’s New Approach to Pain Management Targets Epidemic of Opioid and NSAID Over-Prescribing
September 23, 2014
Clinical Trial Results Confirm Amino Acid Based Medical Food Theramine® More Effective at Improving Chronic Back Pain than NSAID Pain Medications
September 16, 2014
Targeted Medical Pharma to Present at Sachs Associated 14th Annual Biotech in Europe Forum for Global Partnering and Investment